Home
ARAC and partners launch international project to study antibiotic resistance in Iceland.
The CRAU Standard: Certified Responsible Antibiotic Use
Our Specialties
Groundbreaking Research
We prioritize closing critical knowledge gaps regarding the public health impact of antibiotic overuse and misuse in people and animals so that all the major drivers of antibiotic resistance are properly addressed.
Creative Communications
We disseminate information through a range of creative outlets with the aim of fostering an informed public that understands antibiotic resistance and calls for improved antibiotic use policies in people and animals.
Smart Policy
We bring to bear expertise in policy analysis to foster collaboration among policymakers, industry leaders, and consumers to develop evidence-based policies that preserve the effectiveness of antibiotics.
Featured Projects
Consumer-Driven Healthcare
The main consumer-driven healthcare sectors in the U.S. include telemedicine, retail clinics, and urgent care. ARAC is working with key stakeholders in the urgent care sector, together with academic and governmental partners, to address challenges to improve antibiotic stewardship.
Superbugs in Stock
Eight of the 12 largest U.S. supermarket companies, including Walmart and Trader Joe’s, received an “F” on a new report card grading corporate policies regarding antibiotic usage in their private label meat and poultry supplies. Superbugs in Stock was released Oct. 13, 2022.
Label Claim Lacks Integrity
Many consumers choose higher-priced steaks, burgers and other beef products from cattle that have been raised without antibiotics. The USDA approves meat labels with claims such as ‘‘Raised without Antibiotics’, but how confident can shoppers be that they are, in fact, getting what they paid for?
Featured News
A Growing Number of UTIs are Resistant to Antibiotics. Experts Say it's the 'Canary in the Coal Mine' for a Bigger Problem
April 14, 2025
This Yahoo Life story quotes ARAC’s Research Scientist Dan Park in a piece about rising antibiotic resistance in UTIs being the “canary in the coal mine” for a larger public health threat.
Nasal Bacteria May Boost COVID-19 Infection Risk
April 10, 2025
Our study published in eBioMedicine assessed whether the nasal microbiome affects an individual’s risk of SARS-CoV-2 infection, offering fresh insights into factors influencing vulnerability to COVID-19.
Intervention Reduced Inappropriate Antibiotic Use at Urgent Cares
April 4, 2025
Healio highlights research scientist Dan Park in a report on how a multisite intervention significantly reduced inappropriate antibiotic prescribing in urgent care centers.